Asian Journal of Sports Medicine

Published by: Kowsar

Morphine/Codeine Ratio, a Key in Investigating a Case of Doping

Tohid Seif-Barghi 1 , 2 , Navid Moghadam 2 , 3 , * and Farzad Kobarfard 4
Authors Information
1 Sports Medicine Research Center, Tehran University of Medical Sciences, Tehran, IR Iran
2 Iran Football Medical Assessment and Rehabilitation Center (IFMARC), Tehran, IR Iran
3 Sports Medicine Department, Rasool Akram Hospital, Iran University of Medical Sciences, Tehran, IR Iran
4 Department of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Asian Journal of Sports Medicine: December 01, 2015, 6 (4); e28798
  • Published Online: December 1, 2015
  • Article Type: Case Report
  • Received: March 18, 2015
  • Revised: June 28, 2015
  • Accepted: July 3, 2015
  • DOI: 10.5812/asjsm.28798

To Cite: Seif-Barghi T, Moghadam N, Kobarfard F. Morphine/Codeine Ratio, a Key in Investigating a Case of Doping, Asian J Sports Med. 2015 ; 6(4):e28798. doi: 10.5812/asjsm.28798.

Abstract
Copyright © 2015, Sports Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
Acknowledgements
References
  • 1. Findlay JW, Jones EC, Butz RF, Welch RM. Plasma codeine and morphine concentrations after therapeutic oral doses of codeine-containing analgesics. Clin Pharmacol Ther. 1978; 24(1): 60-8[PubMed]
  • 2. Ceder G, Jones AW. Concentration ratios of morphine to codeine in blood of impaired drivers as evidence of heroin use and not medication with codeine. Clin Chem. 2001; 47(11): 1980-4[PubMed]
  • 3. Boerner U. The metabolism of morphine and heroin in man. Drug Metab Rev. 1975; 4(1): 39-73[DOI][PubMed]
  • 4. Shah JC, Mason WD. Plasma Codeine and Morphine Concentrations After a Single Oral Dose of Codeine Phosphate. J Clin Pharmacol. 1990; 30(8): 764-6[DOI]
  • 5. Kronstrand R, Jones AW. Concentration ratios of codeine-to-morphine in plasma after a single oral dose (100 mg) of codeine phosphate. J Anal Toxicol. 2001; 25(6): 486-7[PubMed]
  • 6. He YJ, Brockmoller J, Schmidt H, Roots I, Kirchheiner J. CYP2D6 Ultrarapid Metabolism and Morphine/Codeine Ratios in Blood: Was it Codeine or Heroin? J Anal Toxicol. 2008; 32(2): 178-82[DOI]
  • 7. Kirchheiner J, Schmidt H, Tzvetkov M, Keulen JT, Lotsch J, Roots I, et al. Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication. Pharmacogenomics J. 2007; 7(4): 257-65[DOI][PubMed]
  • 8. Wang B, Yang LP, Zhang XZ, Huang SQ, Bartlam M, Zhou SF. New insights into the structural characteristics and functional relevance of the human cytochrome P450 2D6 enzyme. Drug Metab Rev. 2009; 41(4): 573-643[DOI][PubMed]
  • 9. Crews KR, Gaedigk A, Dunnenberger HM, Leeder JS, Klein TE, Caudle KE, et al. Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update. Clin Pharmacol Ther. 2014; 95(4): 376-82[DOI][PubMed]
  • 10. Llerena A, Dorado P, Penas-Lledo EM. Pharmacogenetics of debrisoquine and its use as a marker for CYP2D6 hydroxylation capacity. Pharmacogenomics. 2009; 10(1): 17-28[DOI][PubMed]
  • 11. Dinama O, Warren AM, Kulkarni J. The role of pharmacogenomic testing in psychiatry: Real world examples. Aust N Z J Psychiatry. 2014; 48(8): 778[DOI][PubMed]
  • 12. McLellan RA, Oscarson M, Seidegard J, Evans DA, Ingelman-Sundberg M. Frequent occurrence of CYP2D6 gene duplication in Saudi Arabians. Pharmacogenetics. 1997; 7(3): 187-91[PubMed]
  • 13. Steimer W, Zopf K, von Amelunxen S, Pfeiffer H, Bachofer J, Popp J, et al. Allele-specific change of concentration and functional gene dose for the prediction of steady-state serum concentrations of amitriptyline and nortriptyline in CYP2C19 and CYP2D6 extensive and intermediate metabolizers. Clin Chem. 2004; 50(9): 1623-33[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments